Silex Systems Ltd (ASX: SLX) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Silex Systems Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Silex Systems Ltd (ASX: SLX)
Latest News
⏸️ Investing
Looking for the mega-trends of the future? These may be the 4 most unique stocks on the ASX
⏸️ Investing
Here's why Silex Systems Ltd crashed this week
⏸️ Investing
Why this bargain growth stock could power you to an early retirement
⏸️ Investing
Your instant 4-share bargain priced portfolio
SLX ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About Silex Systems Ltd
Silex Systems Ltd is an Australian research and development company. The company focused on the development of the SILEX laser uranium enrichment technology as the next-generation technology for the uranium enrichment industry. The company's operating segment includes Silex Systems; Silex USA, and Translucent. It generates maximum revenue from the Silex Systems segment.
SLX Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
24 Apr 2024 | $4.75 | $-0.08 | -1.66% | 261,808 | $4.85 | $4.93 | $4.75 |
23 Apr 2024 | $4.83 | $-0.04 | -0.82% | 200,273 | $4.87 | $4.90 | $4.79 |
22 Apr 2024 | $4.87 | $0.08 | 1.67% | 533,174 | $4.81 | $4.88 | $4.77 |
19 Apr 2024 | $4.79 | $-0.17 | -3.43% | 601,975 | $5.00 | $5.05 | $4.75 |
18 Apr 2024 | $4.96 | $0.04 | 0.81% | 386,830 | $4.89 | $4.98 | $4.89 |
17 Apr 2024 | $4.92 | $0.03 | 0.61% | 388,649 | $4.87 | $4.93 | $4.81 |
16 Apr 2024 | $4.89 | $-0.22 | -4.31% | 535,496 | $5.02 | $5.04 | $4.81 |
15 Apr 2024 | $5.11 | $-0.19 | -3.58% | 313,954 | $5.17 | $5.25 | $5.06 |
12 Apr 2024 | $5.30 | $0.19 | 3.72% | 560,879 | $5.16 | $5.35 | $5.15 |
11 Apr 2024 | $5.11 | $0.03 | 0.59% | 351,733 | $5.06 | $5.14 | $5.02 |
10 Apr 2024 | $5.08 | $-0.09 | -1.74% | 285,903 | $5.15 | $5.20 | $5.04 |
09 Apr 2024 | $5.17 | $-0.02 | -0.39% | 378,651 | $5.13 | $5.17 | $5.07 |
08 Apr 2024 | $5.19 | $0.01 | 0.19% | 557,376 | $5.22 | $5.27 | $5.14 |
05 Apr 2024 | $5.18 | $-0.13 | -2.45% | 394,542 | $5.17 | $5.19 | $5.11 |
04 Apr 2024 | $5.31 | $0.14 | 2.71% | 765,214 | $5.30 | $5.47 | $5.26 |
03 Apr 2024 | $5.17 | $-0.22 | -4.08% | 464,032 | $5.37 | $5.48 | $5.12 |
02 Apr 2024 | $5.39 | $0.26 | 5.07% | 1,179,127 | $5.15 | $5.44 | $4.95 |
28 Mar 2024 | $5.13 | $0.30 | 6.21% | 1,195,131 | $4.89 | $5.14 | $4.85 |
27 Mar 2024 | $4.83 | $0.04 | 0.84% | 349,278 | $4.80 | $4.84 | $4.72 |
26 Mar 2024 | $4.79 | $-0.04 | -0.83% | 264,850 | $4.81 | $4.82 | $4.75 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
23 Aug 2023 | Michael Goldsworthy | Issued | 75,000 | $267,000 |
Issue of securities. 487,500 Performance Rights
|
23 Aug 2023 | Michael Goldsworthy | Exercise | 67,688 | $240,969 |
Conversion of securities. 4,19,812 Rights
|
23 Aug 2023 | Michael Goldsworthy | Expiry | 7,312 | $26,030 |
As advised by the company. Cessation of 7,312 Performance Rights, 4,12,500 Rights
|
23 Aug 2023 | Michael Goldsworthy | Issued | 67,688 | $240,969 |
Conversion of securities.
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Dr Michael Philip Goldsworthy | Chief Executive OfficerManaging Director | Feb 1992 |
Mr Goldsworthy founder of the Company and co-inventor of the SILEX laser isotope separation technology. Dr Goldsworthy has been the guiding force behind the commercialization program for the SILEX technology. He is also Director of Global Laser Enrichment Holdings LLC.
|
Mr Christopher David Wilks | Non-Executive Director | Sep 2007 |
Mr Wilks finance director and CFO of Sonic Healthcare Limited. He has held various directorships of public companies held over the years.
|
Mr Craig Andrew Roy | Non-Executive ChairmanNon-Executive Director | Jan 2019 |
Mr Roy former Deputy CEO of the CSIRO. He has experience as a company director and is currently a Non-executive Director of Sydney Water and Chair of the Australian Research Data Commons.
|
Mr Helen Cook | Non-Executive Director | Oct 2021 |
Mr Cook Is a commercial lawyer and international nuclear law specialist. A Principal of GNE Advisory Pty Ltd, a law practice dedicated to the global civil nuclear energy sector.
|
Ms Julie E Ducie | Company SecretaryChief Financial Officer | Oct 2010 |
-
|
J E Russell | CFO/Company Secretary |
-
|
|
Julie E Ducie | Company SecretaryChief Financial Officer |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
Jardvan Pty Ltd | 29,801,030 | 12.66% |
HSBC Custody Nominees (Australia) Limited | 22,414,510 | 9.52% |
JP Morgan Nominees Australia Pty Limited | 10,788,489 | 4.58% |
Mccusker Holdings Pty Ltd | 8,000,000 | 3.40% |
Citicorp Nominees Pty Limited | 7,489,570 | 3.18% |
Majenta Holdings Pty Ltd | 5,703,923 | 2.42% |
Hillboi Nominees Pty Ltd | 4,100,281 | 1.74% |
BNP Paribas Noms Pty Ltd <Drp> | 3,604,103 | 1.53% |
HSBC Custody Nominees (Australia) Limited <GSCO Customers A/C> | 3,185,997 | 1.35% |
National Nominees Limited | 3,180,836 | 1.35% |
Throvena Pty Ltd | 2,978,203 | 1.27% |
Spar Nominees Pty Ltd | 2,963,234 | 1.26% |
Pure Gold Pty Ltd | 2,520,000 | 1.07% |
Mr Christopher David Wilks | 2,405,070 | 1.02% |
Hamlac Pty Ltd | 2,125,937 | 0.90% |
HSBC Custody Nominees (Australia) Limited <Nt Comnwlth Super Corp A/C> | 2,032,843 | 0.86% |
Quintal Pty Ltd | 2,002,952 | 0.86% |
Sporran Lean Pty Ltd | 1,807,000 | 0.77% |
RD Super Pty Ltd | 1,752,082 | 0.75% |
BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient Drp> | 1,601,678 | 0.68% |